Mar. 23 -- FRIDAY, June 1 (HealthDay News) -- A protein that is used as a marker of heart disease may also predict survival odds and response to chemotherapy for men with advanced prostate cancer.
Can PSA derivatives reduce unnecessary prostate MRI after negative biopsy? Learn how simple markers may guide imaging ...
University Hospitals Seidman Cancer Center researchers have developed a tool that could identify metastatic prostate cancer ...
Research from the University of Cambridge may be able to start a national screening programme for the common cancer ...
Tumor heterogeneity, which refers to variations in the cellular and genetic components between cancer cells within a tumor, can complicate the determination of optimal treatment approaches for ...
Anyone discouraged by the continued absence of a prostate cancer screening programme, the difficulties in getting a clear ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback